Rankings
▼
Calendar
ESLA Q1 2022 Earnings — Estrella Immunopharma, Inc. Revenue & Financial Results | Market Cap Arena
ESLA
Estrella Immunopharma, Inc.
$53M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$168,292
Net Income
-$168,292
EPS (Diluted)
$-0.03
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$107,308
Free Cash Flow
-$107,308
Stock-Based Comp.
$60,984
Balance Sheet
Total Assets
$46M
Total Liabilities
$2M
Stockholders' Equity
$44M
Cash & Equivalents
$321,724
← FY 2022
All Quarters
Q2 2022 →
